Year |
Citation |
Score |
2013 |
Franzini M, Ye XM, Adler M, Aubele DL, Garofalo AW, Gauby S, Goldbach E, Probst GD, Quinn KP, Santiago P, Sham HL, Tam D, Truong A, Ren Z. Triazolopyridazine LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 1967-73. PMID 23454015 DOI: 10.1016/J.Bmcl.2013.02.043 |
0.595 |
|
2013 |
Garofalo AW, Adler M, Aubele DL, Brigham EF, Chian D, Franzini M, Goldbach E, Kwong GT, Motter R, Probst GD, Quinn KP, Ruslim L, Sham HL, Tam D, Tanaka P, et al. Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 1974-7. PMID 23453068 DOI: 10.1016/J.Bmcl.2013.02.041 |
0.586 |
|
2013 |
Garofalo AW, Adler M, Aubele DL, Bowers S, Franzini M, Goldbach E, Lorentzen C, Neitz RJ, Probst GD, Quinn KP, Santiago P, Sham HL, Tam D, Truong AP, Ye XM, et al. Novel cinnoline-based inhibitors of LRRK2 kinase activity. Bioorganic & Medicinal Chemistry Letters. 23: 71-4. PMID 23219325 DOI: 10.1016/J.Bmcl.2012.11.021 |
0.601 |
|
2011 |
Bowers S, Truong AP, Neitz RJ, Neitzel M, Probst GD, Hom RK, Peterson B, Galemmo RA, Konradi AW, Sham HL, Tóth G, Pan H, Yao N, Artis DR, Brigham EF, et al. Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor. Bioorganic & Medicinal Chemistry Letters. 21: 1838-43. PMID 21316234 DOI: 10.1016/j.bmcl.2011.01.046 |
0.355 |
|
2011 |
Probst GD, Bowers S, Sealy JM, Truong AP, Hom RK, Galemmo RA, Konradi AW, Sham HL, Quincy DA, Pan H, Yao N, Lin M, Tóth G, Artis DR, Zmolek W, et al. Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration. Bioorganic & Medicinal Chemistry Letters. 21: 315-9. PMID 21112785 DOI: 10.1016/j.bmcl.2010.11.010 |
0.305 |
|
2010 |
Hom RK, Bowers S, Sealy JM, Truong AP, Probst GD, Neitzel ML, Neitz RJ, Fang L, Brogley L, Wu J, Konradi AW, Sham HL, Tóth G, Pan H, Yao N, et al. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK. Bioorganic & Medicinal Chemistry Letters. 20: 7303-7. PMID 21071223 DOI: 10.1016/j.bmcl.2010.10.066 |
0.323 |
|
2010 |
Kasibhatla SR, Bookser BC, Probst G, Appleman JR, Erion MD. ChemInform Abstract: AMP Deaminase Inhibitors. Part 3. SAR of 3-(Carboxyarylalkyl)coformycin Aglycon Analogues. Cheminform. 31: no-no. DOI: 10.1002/chin.200031218 |
0.304 |
|
2010 |
TROST BM, PROBST GD, SCHOOP A. ChemInform Abstract: Ruthenium-Catalyzed Alder Ene Type Reactions. A Formal Synthesis of Alternaric Acid. Cheminform. 30: no-no. DOI: 10.1002/chin.199903227 |
0.408 |
|
2004 |
Trost BM, Yang H, Probst GD. A formal synthesis of (-)-mycalamide A. Journal of the American Chemical Society. 126: 48-9. PMID 14709053 DOI: 10.1021/Ja038787R |
0.469 |
|
1998 |
Trost BM, Probst GD, Schoop A. Ruthenium-catalyzed alder ene type reactions. A formal synthesis of alternaric acid Journal of the American Chemical Society. 120: 9228-9236. DOI: 10.1021/Ja981540N |
0.52 |
|
Show low-probability matches. |